Elanco Animal's Outlook Lags Street Expectations But Analyst Sees Time For Elanco's Commercial Investment To Payoff
1. Elanco reported Q4 revenue of $1.02B, beating consensus. EPS increased YoY but missed expectations. 2. Pet Health revenue grew 6%, while Farm Animal results were mixed. Competition pressured veterinary channel sales. 3. Guidance for 2025 revenues and EPS fell slightly below consensus. FX headwinds and commercial investments are key concerns. 4. Adjusted EBITDA and margins improved significantly. Stock fell 4.68%, reflecting negative investor sentiment.